PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that its wholly owned subsidiary, Cody Laboratories (Cody), a manufacturer/supplier of bulk active pharmaceutical ingredients (API) acquired by Lannett in April 2007, has received approval for its import registration application from the U.S. Drug Enforcement Administration (DEA). This approval allows Lannett, through Cody, to directly import raw materials for processing into controlled substance pain management products.
